<DOC>
	<DOCNO>NCT00506532</DOCNO>
	<brief_summary>1 . Working Hypothesis : The purpose trial study effect exogenous calf surfactant ( calfactant ) prevention primary graft failure due ischemic-reperfusion lung injury lung transplant patient . 2 . Aims Study : The purpose trial study effect exogenous calf surfactant ( calfactant ) prevention primary graft failure due ischemic-reperfusion lung injury lung transplant patient .</brief_summary>
	<brief_title>The Use Surfactant Lung Transplantation : A Randomized Control Pilot Study</brief_title>
	<detailed_description>Background : Lung transplantation induces surfactant dysfunction may contribute factor primary graft dysfunction ( PGD ) graft failure . Animal study limit human report suggest surfactant administration may prevent primary graft dysfunction . Working hypothesis aim : The purpose trial study effect exogenous calf surfactant ( calfactant ) prevention primary graft failure due ischemic-reperfusion lung injury lung transplant patient . Methods : The trial open randomize control prospective study . Patient population : 42 patient eligible lung transplant accord hospital criterion . Study medication : Calfactant intratracheal suspension -an extract natural surfactant calf lung , include phospholipid , neutral lipid surfactant-associated protein B C ( SP-B SP-C ) . Study design : Patients randomize receive calfactant drug administer fiberoptic bronchoscope distribute drug evenly across lung immediately connection . The patient administration avoid excessive flushing . When 2 lung use donor 2 recipient one patient receive one lung treat calfactant patient receive lung treat serve control . Otherwise lung treat surfactant every case . Expected result : We expect surfactant instillation lung transplantation improve oxygenation , prevent primary graft dysfunction , make intubation time short enhance early post transplantation recovery . In pilot study already perform result encourage . Importance : PGD could cause substantial morbidity mortality among transplanted patient . In pilot study already find surfactant instillation lung transplantation improve oxygenation , prevents primary graft dysfunction , shorten intubation time ICU stay . We believe surfactant treatment enhances early post transplantation recovery , may also cost effective shorten expensive ICU stay .</detailed_description>
	<mesh_term>Primary Graft Dysfunction</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<mesh_term>Calfactant</mesh_term>
	<criteria>Candidates lung transplantation Differential diagnosis PGD Pulmonary Edema Stenosis thrombosis pulmonary artery/vein anastomosis</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Pulmonary Surfactants</keyword>
	<keyword>Lung transplantation</keyword>
	<keyword>Primary Graft Dysfunction</keyword>
</DOC>